National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Anxiety Disorder (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 05/15/2008



Introduction






Overview






Description and Cause






Treatment






Post-treatment Considerations






Get More Information From NCI






Changes to This Summary (05/15/2008)






Questions or Comments About This Summary






About PDQ



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Post-treatment Considerations

After cancer therapy has been completed, a cancer survivor may be faced with new anxieties. Survivors may experience anxiety when they return to work and are asked about their cancer experience, or when confronted with insurance-related problems. A survivor may fear subsequent follow-up examinations and diagnostic tests, or they may fear a recurrence of cancer. Survivors may experience anxiety due to changes in body image, sexual dysfunction, reproductive issues, or post-traumatic stress. Survivorship programs, support groups, counseling, and other resources are available to help people readjust to life after cancer.

See the following PDQ summaries for more information:

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov